Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure-Reference-Cited by-同舟云学术

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

Published:2004-06-08 Issue:5 Volume:6 Page:635-641
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Tavazzi Luigi¹,Tognoni Gianni²,Franzosi Maria Grazia³,Latini Roberto³,Maggioni Aldo Pietro⁴,Marchioli Roberto²,Nicolosi Gian Luigi⁵,Porcu Maurizio⁶,

Affiliation:

1. Policlinico San Matteo, IRCCS; Pavia Italy

2. Consorzio Mario Negri Sud; Santa Maria Imbaro Italy

3. Istituto di Ricerche Farmacologiche ‘Mario Negri; Milano Italy

4. Centro Studi ANMCO; Firenze Italy

5. Ospedale Santa Maria degli Angeli; Pordenone Italy

6. Ospedale San Michele ‘G. Brotzu’; Cagliari Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Congestive heart failure: a half century perspective;Braunwald;Eur Heart J,2001

2. Effects of enalapril in severe congestive heart failure;The CONSENSUS Trial Study Group;N Engl J Med,1987

3. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure;Cohn;N Engl J Med,1991

4. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;The SOLVD Investigators;N Engl J Med,1991

5. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure;Packer;N Engl J Med,1996

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of secretoneurin in chronic heart failure. Data from the GISSI-Heart Failure trial;Clinical Biochemistry;2023-08

2. Beta‐blocker use and mortality among patients with systolic heart failure and pacemaker rhythm;ESC Heart Failure;2023-03-30

3. Marine-derived n-3 fatty acids therapy for stroke;Cochrane Database of Systematic Reviews;2022-06-29

4. LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial;Clinical Chemistry;2021-11-24

5. Coffee, Atrial Fibrillation, and Circulating Ceramides in Patients with Chronic Heart Failure;Journal of Agricultural and Food Chemistry;2021-09-17